New Products In Brief

CryoLife CryoPatch SG: Cardiac patch gains 510(k) clearance for repair or reconstruction of the right ventricular outflow tract, announced Aug. 12. Processed with CryoLife's proprietary SynerGraft technology, the human collagen matrix device addresses a niche U.S. market worth about $15 million, according to the company. Right ventricular outflow tract repair or reconstruction is commonly performed in children with congenital heart defects, such as Tetralogy of Fallot, Truncus Arteriosus and Pulmonary Atresia. The device is available in three anatomic configurations: pulmonary hemi-artery, pulmonary trunk and pulmonary branch. Shipments will start by the end of September, CryoLife says